Telaprevir's Efficacy Against Hepatitis C Trumps Standard Treatment
Results of the PROVE3 trial found that drug regimens using telaprevir were more effective against Hepatitis C than regimens without telaprevir in both treatment naïve patients and previous treatment non-responders.
Continue reading »